Mid-market growth fund research profile
Motilal Oswal Alternates is the group’s India-focused alternatives platform investing in established mid-market companies with growth characteristics and leading positions. Its private-equity franchise sits alongside real estate and private credit, with a research-led value-investing philosophy.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Motilal Oswal Alternates uses a mid-market growth approach across Consumer, fin services, niche manufacturing, health.
Current evidence
Motilal Oswal reported in February 2026 that India Business Excellence Fund V closed at ₹8,500 crore, above its initial target, with a 51-company portfolio and more than $1 billion in liquidity; the 2025 first-close announcement identified AU, Dixon and Uno Minda as scaled businesses backed by the platform.
Strategy
Mid-market growth
Sector focus
Consumer, fin services, niche manufacturing, health
AIF structure context
Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.
Current signal
Motilal Oswal reported in February 2026 that India Business Excellence Fund V closed at ₹8,500 crore, above its initial target, with a 51-company portfolio and more than $1 billion in liquidity; the 2025 first-close announcement identified AU, Dixon and Uno Minda as scaled businesses backed by the platform.
Investor questions
Motilal Oswal Alternates is covered in Rupeia's private equity research universe. The current public record describes the strategy as Mid-market growth, with a sector focus of Consumer, fin services, niche manufacturing, health. The profile should be read with the linked source trail and Typical route: Category II AIF context.
The profile displays only company or asset names attributable to Motilal Oswal Alternates in the reviewed public sources: AU Small Finance Bank, Dixon Technologies, Kurlon, Molbio Diagnostics, IKF Finance, VVDN Technologies, N. Ranga Rao & Sons, Minda Industries, GR Infraprojects. It does not represent a complete current portfolio unless the manager has published one.
The manager reports 50 private-equity investments and 23 successful exits, including a 26.8% portfolio IRR for IBEF I and a disclosed 5.3x MOIC / 30%+ IRR on Happy Forgings. These are manager-reported fund or deal outcomes and should not be conflated with net LP returns. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: IBEF I was ₹550 Cr, IBEF II approximately ₹1,000 Cr, and IBEF V closed at ₹8,500 Cr in 2026; the platform also reports around ₹28,000–30,000 Cr cumulative AUM across strategies.. Public terms or access information: Mid-market growth and buyout-style investments across consumer, financial services, life sciences and niche manufacturing; current cheque and reserve policy varies by vintage.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Vishal Tulsyan. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: Independent verification of historical fund-level IRR/MOIC claims remains open; current vehicle terms are not fully disclosed..
2026: Motilal Oswal reported in February 2026 that India Business Excellence Fund V closed at ₹8,500 crore, above its initial target, with a 51-company portfolio and more than $1 billion in liquidity; the 2025 first-close announcement identified AU, Dixon and Uno Minda as scaled businesses backed by the platform.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.